Molnupiravir

This is not medical advice. Always consult a licensed healthcare professional before starting or changing any treatment. Information here is based on personal experiences and may not apply to everyone.

Alternative Names: Lagevrio

Molnupiravir is an oral antiviral medication used to treat mild to moderate COVID-19 in adults at high risk of severe illness. It must be started within 5 days of symptom onset and is taken as capsules for 5 days. While it can reduce the risk of hospitalization, it is generally considered less effective than other treatments like Paxlovid.

Molnupiravir is used to treat COVID-19 when Paxlovid isn’t suitable—such as in patients with certain drug interactions, or kidney or liver problems. While it’s less effective than Paxlovid, it’s a useful backup option when other treatments aren’t safe or available.

Treatment Type: Prescription Medication

Treatment Class: Antiviral

Treatment Modality: Oral

Review Summary

4.0

1 Reviews

Preferred by 1 Reviewers

Based on the single review provided, Molnupiravir appears to be a valuable oral antiviral treatment for COVID-19, particularly when other treatments like Paxlovid are not suitable due to drug interactions or kidney/liver issues. Although less effective than Paxlovid, Molnupiravir serves as an important alternative treatment option.

This summary was generated by users' reviews

Breakdown by Category

Each categories are rated on a 1–5 scale, with 5 being the most favorable outcome and 1 being the least. These scores are averaged across all user reviews to provide a clear sense of how this treatment typically performs in each area.

Cost

1.0

1 = Very Expensive 5 = Very Affordable

1.0

Very Expensive

Relief Speed

3.0

1 = No Relief 5 = Immediate Relief

3.0

Moderate Relief

Side Effects

4.0

1 = Intolerable Effect 5 = No Effect

4.0

Mild Effect

Treatment Line

1.0

1 = Third-line or more 5 = First-line

1.0

Third-line or more

Choose treatments from the menu above to see how they compare side by side.

4.0

1 Reviews

100%

AI Summary of User Experiences

Not medical advice.

Reviews

Filter by reviewer type Pro

Select all Clear all

Cost

Very Expensive

$1000+

Expensive

$501 to $1000

Moderate Cost

$101 to $500

Affordable

$25 to $100

Very Affordable

$25

Relief Speed

No Relief

No noticeable improvement

Slow Relief

Several days to weeks

Moderate Relief

Within 1 - 3 days

Fast Relief

Within hours

Immediate Relief

Within minutes

Side Effect

Intolerable Side Effect

Caused treatment to stop or required hospitalization

Severe Side Effect

Difficult to tolerate, may require intervention

Moderate Side Effect

Noticeable, but manageable

Mild Side Effect

Minor, not bothersome

No Side Effect

Without any adverse effects

Treatment Line

Third-line or more

Used after second-line failed or multiple prior treatment

Second-line

Used after first-line treatment failed or was unsuitable

First-line

First treatment tried

Dr. Curbside

Verified

Physician • Emergency Medicine • How doctors think about decisions — and what real-world experiences add

2 months ago

Molnupiravir is an oral antiviral for COVID-19, used when Paxlovid isn’t appropriate due to drug interactions or kidney/liver issues. While less effective than Paxlovid, it’s a valuable alternative when other treatments aren’t suitable.

#VeryExpensive #CoveredByInsurance #ModerateRelief #MildEffect #Third-lineOrMore #Rescue/EmergencyUse

View Professional Disclosures

We use cookies to personalize our services and provide you with the best possible experience. By continuing to use this site, you agree to this cookie usage. We also use third-party cookies that help us analyse how you use this website, store your preferences, and provide the content and advertisements that are relevant to you. These cookies will only be stored in your browser with your prior consent. You can learn more about cookies and how your data is processed in the Privacy Policy.

Strictly Necessary Only Accept All